Brief: Polypid Announces Successful Commercial Good Manufacturing Practice Audit By Israeli Ministry Of Health
21/09/2023 12:51
Sept 21 (Reuters) - PolyPid Ltd PYPD.O :
* POLYPID ANNOUNCES SUCCESSFUL COMMERCIAL GOOD MANUFACTURING
PRACTICE (GMP) AUDIT BY ISRAELI MINISTRY OF HEALTH
* POLYPID LTD - CAN NOW PRODUCE D-PLEX(100) AT SCALE IN
ORDER TO
FULFILL EXPECTED COMMERCIAL DEMAND FOR PRODUCT
* POLYPID LTD - AUDIT CONCLUDED CO'S MANUFACTURING FACILITY,
PROCESS AND QUALITY SYSTEM CONFORM TO REQUIREMENTS OF CURRENT
GMP FOR MEDICINAL PRODUCTS
Source text for Eikon: ID:nGNXbZpfNZ
Further company coverage: PYPD.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Polypid
See all newsPolyPid Ltd reports results for the quarter ended June 30 - Earnings Summary
PolyPid Ltd expected to post a loss of 38 cents a share - Earnings Preview
Brief: Polypid Announces FDA Acceptance Of NDA With Priority Review For D-Plex₁₀₀
PolyPid, Azurity sign surgical site infection drug deal
Brief: Polypid Initiates D-Plex₁₀₀ NDA Submission To The FDA